编辑精选——欧洲德尔菲共识:遗传性主动脉疾病患者腹主动脉瘤的管理
该德尔菲共识由欧洲多学科专家参与,经四轮邮件调查,旨在为遗传性主动脉疾病(HAD)相关腹主动脉瘤(AAA)的诊断、治疗和随访提供共识。最终问卷97条陈述中,16条(16%)为A级(非常强),23条(24%)为B级(强),5条(5%)为C级(一般),44条(45%)为D级(未达成共识),9条(9%)无效。
要点
- 共识强调多学科主动脉团队在HAD相关AAA管理中的作用。
- 共识涉及影像学与基因诊断、治疗及随访等关键环节。
- 专家指出需为每种疾病开发个体化治疗,并建立国际多中心数据库。
核心结论
- 该德尔菲流程在HAD相关AAA患者的多个管理方面达成共识,为更标准化的管理提供指导。
- 达成的共识聚焦于多学科主动脉团队、影像与基因诊断、治疗及随访。
- 同时识别出若干未来研究方向。
研究设计与样本
- 德尔菲共识,涉及欧洲多学科专家,采用ACCORD报告规范。
- 共进行四轮邮件调查:前两轮确定问卷内容,后两轮达成共识。
- 共35名专家参与,来自18家不同医院和10个不同国家:19名血管外科医生、11名心脏病专家、4名遗传学家和1名心脏外科医生。
- 最终问卷共97条陈述。
主要发现
- 97条陈述中,16条(16%)为A级(非常强),23条(24%)为B级(强),5条(5%)为C级(一般),44条(45%)为D级(未达成共识),9条(9%)无效。
- 专家强调需为每种疾病开发个体化治疗。
- 专家强调需建立国际多中心数据库以收集HAD相关AAA患者自然病程数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Abdominal aortic aneurysm (AAA) in a patient with an underlying heritable aortic disease (HAD) is rare, and evidence based recommendations for its management are lacking. This study aimed to generate a consensus from multidisciplinary specialists on the diagnosis, treatment, and surveillance of AAA associated with HAD and to define topics of interest for future research. METHODS: A Delphi consensus was designed involving European multidisciplinary specialists and reported using the ACcurate COnsensus Reporting Document (ACCORD) reporting guideline. Four rounds were carried out by email: the first two rounds to agree on the content of the questionnaire and the final two rounds to reach an agreement. Questions focused on the composition of the team, imaging, clinical suspicion, genetic testing, medical management, indications for surgical repair, surgical technique, surveillance, exercise, and quality of life. The level of agreement for each question was graded using a Likert type scale and classified into four categories: A (very strong), B (strong), C (fair), and D (no agreement). RESULTS: A total of 35 experts from 18 different hospitals and 10 different countries participated in the study: 19 vascular surgeons, 11 cardiologists, four geneticists, and one cardiac surgeon. Of the 97 statements of the final questionnaire, 16 were graded A (16%), 23 B (24%), five C (5%), 44 D (45%) and nine (9%) were invalid. The experts highlighted the need to develop personalised therapies for each pathology, as well as international multicentre databases to collect data on the natural course of AAA patients with HAD. CONCLUSION: This Delphi process led to consensus on several aspects of care for patients with AAA and underlying HAD, providing guidance to manage them in a more standardised fashion. The agreements reached focus on multidisciplinary aortic teams, imaging and genetic diagnosis, treatment, and follow up. Furthermore, several topics for future research were identified.
引用
- Gil-Sala D, De Backer J, Van Herzeele I, et al. Editor's Choice - A European Delphi Consensus on the Management of Abdominal Aortic Aneurysms in Patients with Heritable Aortic Diseases. Eur J Vasc Endovasc Surg. 2025. PMID: 39864495. doi:10.1016/j.ejvs.2025.01.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。